Mutation studies in CD3+, CD19+ and CD34+ cell fractions in myeloproliferative disorders with homozygous JAK2V617F in granulocytes

被引：49

作者：

Lasho, TL ^{[1
]}

Mesa, R

Gilliland, DG

Tefferi, A

机构：

[1] Mayo Clin Rochester, Rochester, MN USA

[2] Mayo Clin Coll Med, Rochester, MN USA

[3] Harvard Univ, Sch Med, Boston, MA USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2005年 / 130卷 / 05期

关键词：

myeloproliferative disorder; mutation analysis; clonality;

D O I：

10.1111/j.1365-2141.2005.05682.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：797 / 799

页数：3

相关论文

共 6 条

[1] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, EJ
Scott, LM
Campbell, PJ
East, C
Fourouclas, N
Swanton, S
Vassiliou, GS
Bench, AJ
Boyd, EM
Curtin, N
Scott, MA
Erber, WN
Green, AR
[J]. LANCET, 2005, 365 (9464) : 1054 - 1061
[2] JAMES C, 2005, IN PRESS NATURE
[3] A gain-of-function mutation of JAK2 in myeloproliferative disorders
Kralovics, R
Passamonti, F
Buser, AS
Teo, S
Tiedt, R
Passweg, JR
Tichelli, A
Cazzola, M
Skoda, RC
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) : 1779 - 1790
[4] Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia
Reeder, TL
Bailey, RJ
Dewald, GW
Tefferi, A
[J]. BLOOD, 2003, 101 (05) : 1981 - 1983
[5] Steensma DP, 2005, BLOOD
[6] TEFFRI A, 2005, IN PRESS CELL CYCLE